Additional file 1 of S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function

Abstract

Additional file 1:Supplementary Fig. S1. Clinical efficacy of pembrolizumab in patients with advanced HCC. a Kaplan–Meier survival curves showing progression-free survival stratified by pembrolizumab group (red) and placebo group (blue). Significance calculated by the log-rank test. b Spider plot showing tumor responses over a long duration